Skip to main content

Table 5 Number and percentage of infested dogs examined on pre- and post-treatment days

From: Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®

Study days

Number of positive dogs per endoparasite species (%)

Trichuris vulpis

Ancylostomatidae

Capillaria aerophila

Toxocara canis

Toxascaris leonina

Dipylidium caninum a

Day 0

20/41 (48.8)

15/41 (36.6)

8/41 (19.5)

6/41 (14.6)

7/41 (17.1)

3/41 (7.3)

Day 14

1/41 (2.4)

9/41 (22.0)

0/41 (0)

0/41 (0)

0/41 (0)

0/41 (0)

Day 28

2/41 (4.9)

15/41 (36.6)

4/41 (9.8)

0/41 (0)

0/41 (0)

1/41 (2.4)

Day 56

1/41 (2.4)

15/41 (36.6)

0/41 (0)

0/41 (0)

0/41 (0)

0/41 (0)

Day 84

1/39 (2.6)

10/39 (25.6)

0/39 (0)

1/39 (2.6)

0/39 (0)

0/39 (0)

Day 112

0/37 (0)

12/37 (32.4)

0/37 (0)

1/37 (2.7)

0/37 (0)

0/37 (0)

Day 140

0/37 (0)

13/37 (35.1)

0/37 (0)

0/37 (0)

0/37 (0)

0/37 (0)

Day 168

0/37 (0)

10/37 (27)

0/37 (0)

0/37 (0)

0/37 (0)

0/37 (0)

  1. aDogs found infected with Dipylidium caninum were treated with praziquantel, since this tapeworm species is not targeted by the two products tested in the study